Skip to content

DOKTER A. AGTEN

Active
Private limited companyfounded 2006active for 19 yearsVoortstraat 80, 3580 Beringen, BelgiumKBO/BCE: BE 0886.007.007
Summary

DOKTER A. AGTEN has been active since 2006 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €81,968. Equity is growing by about 6.1% per year across the filed financial years. Its solvency ranks better than 91% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
9th largest company by equity in Beringen, Health and social work sector
Size
€1.2mtotal assets 2025
Equity
€1.2m
Profit
€81,968
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 84 days early1 of 3 deeds summarised
Why 93lowers riskSector: Human health activities (NACE 86)Size: total assets €1.2mFigures for financial year 2025 (filed 11-05-2026)Equity €1.2m (94.7% of total assets)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 41% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 94.7% of total assets
Liquidity 54-3
short-term debt 5.0% · cash 3.5%
Profitability 77-1
return on assets 6.7%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025highest value 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €100,000 on 30-day terms is acceptable
Liquidity ample (current ratio 19.33, compared with 16.21 in 2024, above the usual 1.5; short-term debt: 5% and cash: 3.5% of total assets), and 5.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 29% on liquidity, 22% on profitability and 33% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €1.2m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 11-05-2026)
NBB · annual accounts
lowers risk · Equity €1.2m (94.7% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-05-2026, 84 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
84 days early
2024
77 days early
2023
55 days early
2022
41 days early
2021
60 days early
2020
39 days early
2019
23 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 54 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
26-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Resignation: AGTEN Albert Willy Lucien Marcel…Reappointment: AGTEN Albert Willy Lucien…
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: Among the best 5% on equitysector median €124,504 · 20,614 companies €1.2m View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €81,968 8 years View

By topic

Financials

Financial year
2025
Total assets
€1.2m
Profit
€81,968
Solvency
94.7%
Total assets▼ 2.6%
Net result
20182025
Go to Financials

Timeline

Events
24
Since
2007
Next accounts
by 31-07-2027
  1. 31-12-2024Highest result from 2018 to 2025
  2. 06-06-2024Annual accounts filed
  3. 31-12-2023Equity above €1m
Go to Timeline

Company details

Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
29-12-2006
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
35
Annual meeting
First Thursday of May at 18:00
Purpose
“1.De uitoefening van de geneeskunde door de geneesheer-vennoot,in naam en voor rekening…” (deed in Dutch)
Go to Articles of association

Key facts about DOKTER A. AGTEN

What is the company number of DOKTER A. AGTEN?
0886.007.007. In Belgium the VAT number is the company number with BE in front: BE 0886.007.007.
Where is DOKTER A. AGTEN based?
The registered office is at Voortstraat 80, 3580 Beringen.Company details
What does DOKTER A. AGTEN do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DOKTER A. AGTEN?
Private limited company (BV).
When was DOKTER A. AGTEN founded?
On 29-12-2006.
Is DOKTER A. AGTEN still active?
Yes, DOKTER A. AGTEN is an active enterprise in the KBO register.
What is the turnover of DOKTER A. AGTEN?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DOKTER A. AGTEN profitable?
In financial year 2025, DOKTER A. AGTEN made a profit of €81,968.
Where can I find the annual accounts of DOKTER A. AGTEN?
DOKTER A. AGTEN filed 20 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER A. AGTEN due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DOKTER A. AGTEN

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.